Prognostic value of mean platelet volume in non-small cell lung cancer: a real-world, registry-based study
K. Cholidou (Athens, Greece), N. Anagnostopoulos (Athens, Greece), D. Grapsa (Athens, Greece), I. Gkiozos (Athens, Greece), E. Kokkotou (Athens, Greece), A. Vassias (Athens, Greece), S. Tsagouli (Athens, Greece), P. Bakakos (Athens, Greece), I. Kotteas (Athens, Greece), A. Charpidou (Athens, Greece)
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Cholidou (Athens, Greece), N. Anagnostopoulos (Athens, Greece), D. Grapsa (Athens, Greece), I. Gkiozos (Athens, Greece), E. Kokkotou (Athens, Greece), A. Vassias (Athens, Greece), S. Tsagouli (Athens, Greece), P. Bakakos (Athens, Greece), I. Kotteas (Athens, Greece), A. Charpidou (Athens, Greece). Prognostic value of mean platelet volume in non-small cell lung cancer: a real-world, registry-based study. 3037
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: